![David Rokach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Rokach
Direttore Finanziario/CFO presso
BIOMX INC.
Profilo
David Rokach is currently Director at Nukkleus, Inc. (New Jersey) since 2024 and Chief Financial & Accounting Officer at BiomX, Inc. starting in 2026.
Formerly, Mr. Rokach was an Independent Director at T3 Defense, Inc.
Posizioni attive di David Rokach
| Società | Posizione | Inizio |
|---|---|---|
| BIOMX INC. | Direttore Finanziario/CFO | 27/02/2026 |
Nukkleus, Inc. (New Jersey)
 Nukkleus, Inc. (New Jersey) Financial ConglomeratesFinance Provides blockchain and digital financial services | Direttore/Membro del Consiglio | 01/01/2024 |
Precedenti posizioni note di David Rokach
| Società | Posizione | Fine |
|---|
Formazione di David Rokach
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Nukkleus, Inc. (New Jersey)
Nukkleus, Inc. (New Jersey) Financial ConglomeratesFinance Provides blockchain and digital financial services | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
